Lake Street raised the firm’s price target on LeMaitre (LMAT) to $110 from $105 and keeps a Buy rating on the shares, telling investors that the company “capped out 2024 with continued robust execution.” The firm continues to expect price increases, new approvals, new reps, and international growth to support 2025 guidance and thinks the company has “the capacity to make its largest acquisition in history if the right opportunity presents itself,” the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LMAT:
- LeMaitre downgraded to Market Perform from Outperform at Barrington
- LeMaitre price target raised to $113 from $100 at Citizens JMP
- Lemaitre Vascular: Strong Financial Performance and Promising Prospects Justify Buy Rating and Raised Price Target
- LeMaitre Vascular Reports Strong Q4 2024 Results
- LeMaitre sees FY25 EPS $2.15-$2.32, consensus $2.16